These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6925461)

  • 41. Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.
    Liberati AM; Brugia M; Edwards BS; Bertoni P; Ballatori E; Puxeddu A; Grignani F
    Cancer Immunol Immunother; 1985; 19(2):136-41. PubMed ID: 3872709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the activity of liver cystic echinococcosis using the delayed-hypersensitivity skin reaction to common antigens.
    Kacprzak E; Stefaniak J
    Ann Trop Med Parasitol; 1995 Feb; 89(1):25-9. PubMed ID: 7741591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.
    Band PR; Levine PH; Patwardhan VC; Shnitka TK; Pabst HF
    Can Med Assoc J; 1973 Jan; 108(2):183-6. PubMed ID: 4346314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delayed hypersensitivity responses of cancer patients to recall antigens using a new "Multitest" applicator.
    Lapham SC; Skipper BE; Coons TA
    Ann Allergy; 1987 Jan; 58(1):85. PubMed ID: 3800057
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunomodulating activity of RU 41740: in vitro and in vivo studies on human lymphocytes.
    Meroni PL; Barcellini W; Sguotti C; Capsoni F; Palmieri R; Guidi G; Zanussi C
    Int J Immunopharmacol; 1987; 9(2):185-90. PubMed ID: 3583509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunocompetence, immunodeficiency and prognosis in cancer.
    Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
    Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas.
    Herberman RB; McCoy JL; Levine PH
    Cancer Res; 1974 May; 34(5):1222-7. PubMed ID: 4366992
    [No Abstract]   [Full Text] [Related]  

  • 49. Skin reactivity to bacterial antigens in Hodgkin's disease.
    Rasiewicz W; Kardaszewicz E
    Pol Med J; 1969; 8(5):1203-8. PubMed ID: 5383935
    [No Abstract]   [Full Text] [Related]  

  • 50. Serial delayed cutaneous hypersensitivity skin testing with multiple recall antigens in healthy volunteers: booster effect study.
    Lesourd BM; Wang A; Moulias R
    Ann Allergy; 1985 Nov; 55(5):729-35. PubMed ID: 4061981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-specificity of transfer factor.
    Khan A
    Ann Allergy; 1977 May; 38(5):320-2. PubMed ID: 855952
    [No Abstract]   [Full Text] [Related]  

  • 52. [Delayed hypersensitivity reactions in cancer patients: influence of the clinical stage and chemo- and radiotherapy on the immune status].
    Bouckenaere-Wojcik D; Delzenne G; Deckers C
    Bull Cancer; 1982; 69(5):468-75. PubMed ID: 7165809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delayed cutaneous hypersensitivity ad peripheral blood lymphocyte counts in gastrointestinal cancer.
    Gupta S; Seth SK; Udupa KN; Sen PC
    Ann Acad Med Singap; 1980 Jan; 9(1):71-6. PubMed ID: 7447383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer.
    Tripodi D; Parks LC; Brugmans J
    N Engl J Med; 1973 Aug; 289(7):354-7. PubMed ID: 4718515
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection.
    Martínez-Marcos FJ; López-Cortés LF; Pachón J; Alarcón A; Cordero E; Viciana P
    Clin Infect Dis; 1998 Jun; 26(6):1330-4. PubMed ID: 9636858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.
    Miller TP; Grogan TM; Dalton WS; Spier CM; Scheper RJ; Salmon SE
    J Clin Oncol; 1991 Jan; 9(1):17-24. PubMed ID: 1670642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cutaneous delayed hypersensitivity in a French reference population using the cell-mediated immunity multitest device].
    Biron G; Roumiantzeff M; Ajjan N; Richard C; Tixier G; Serrou B
    Ann Anesthesiol Fr; 1981; 22(3):270-8. PubMed ID: 6117233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Delayed hypersensitivity reaction to 2,4-dinitrochlorobenzol in cancer patients undergoing cytostatic chemotherapy].
    Brun F; Brunner KW
    Schweiz Med Wochenschr; 1971 Aug; 101(34):1235-43. PubMed ID: 5141781
    [No Abstract]   [Full Text] [Related]  

  • 60. Impaired delayed type cutaneous hypersensitivity in rheumatoid arthritis reversed by chrysotherapy.
    Smith MD; Smith A; O'Donnell J; Ahern MJ; Roberts-Thomson PJ
    Ann Rheum Dis; 1989 Feb; 48(2):108-13. PubMed ID: 2494956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.